The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Shulgina A.A.

Burdenko Neurosurgical Center

Lukshin V.A.

Burdenko Neurosurgical Center

Korshunov A.E.

Burdenko Neurosurgical Center

Belousova O.B.

Burdenko Neurosurgical Center

Pronin I.N.

Burdenko Neurosurgical Center

Usachev D.Yu.

Burdenko Neurosurgical Center

Modern trends in diagnosis and surgical treatment of moyamoya disease

Authors:

Shulgina A.A., Lukshin V.A., Korshunov A.E., Belousova O.B., Pronin I.N., Usachev D.Yu.

More about the authors

Journal: Burdenko's Journal of Neurosurgery. 2020;84(4): 90‑103

DOI: 10.17116/neiro20208404190

Views: 3610

Downloaded: 107

Download PDF (RU)
Download PDF
Contact the author
Table of contents

To cite this article:

Shulgina AA, Lukshin VA, Korshunov AE, Belousova OB, Pronin IN, Usachev DYu. Modern trends in diagnosis and surgical treatment of moyamoya disease. Burdenko's Journal of Neurosurgery. 2020;84(4):90‑103. (In Russ., In Engl.)
https://doi.org/10.17116/neiro20208404190

 
МСФ на ЯМ
Close metadata
Recommended articles:
Features of apha­sic diso­rders in patients with acute cere­brovascular diso­rder in the posterior cere­bral artery basin. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3-2):18-22
The rela­tionship between the deve­lopment of post-stroke cognitive impairment and changes in the coagulation component of hemo­stasis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3-2):23-29
The multidirectional effe­cts of thro­mbin and the possibility of their control in neurology. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3-2):42-48
Comparative characteristics of the effi­cacy and safety of the original alte­plase and its complete biosimilar in the treatment of ischemic stroke in real clinical practice. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3-2):49-54
Effi­cacy of Mexi­dol in combination with cere­bral reva­scularization in the treatment of ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3-2):67-74
Moyamoya disease in adults: treatment methods in modern era. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3-2):75-82
The secretome of mese­nchymal stro­mal cells as a new hope in the treatment of acute brain tissue inju­ries. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3-2):83-91
Hemo­dynamics and repe­rfusion in acute ischemic stroke: friends or foes?. Russian Journal of Anesthesiology and Reanimatology. 2024;(2):91-96
Analysis of stroke inci­dence seasonal changes in Bishkek. Russian Journal of Preventive Medi­cine. 2024;(4):89-96
Methods of cost-effectiveness evaluation of endo­vascular patent fora­men ovale closure for seco­ndary prevention of cryptogenic stroke. Russian Journal of Preventive Medi­cine. 2024;(6):105-110

This review is devoted to moyamoya disease. It is a rare chronic steno-occlusive cerebrovascular disease. However, moyamoya disease is increasingly diagnosed by neurosurgeons in our country. Unlike atherosclerotic lesions of cerebral arteries, pathogenesis and course of this disease are much more complex and variable. Therefore, specialists often have certain difficulties in diagnosis, management and treatment of these patients. To date, a large number of surgical interventions have been proposed for the treatment of moyamoya disease. Revascularization approaches include direct procedures (extra-intracranial microanastomoses), indirect methods (synangioses) and combined revascularization. The purpose of the review is to systematize current literature data on the pathogenesis, diagnosis, clinical patterns and surgical treatment of patients with moyamoya disease. results Outcomes of surgical revascularization and the role of its various components in combined approach are under particular attention.

Keywords:

moyamoya disease
angiopathy
ischemic stroke
surgical revascularization
combined revascularization
extra-intracranial microanastomosis

Authors:

Shulgina A.A.

Burdenko Neurosurgical Center

Lukshin V.A.

Burdenko Neurosurgical Center

Korshunov A.E.

Burdenko Neurosurgical Center

Belousova O.B.

Burdenko Neurosurgical Center

Pronin I.N.

Burdenko Neurosurgical Center

Usachev D.Yu.

Burdenko Neurosurgical Center

Received:

13.04.2020

Accepted:

24.04.2020

List of references:

  1. Takeuchi K, Shimizu K. Hypoplasia of the bilateral internal carotid arteries. No To Shinkei: Brain and Nerve. 1957;9:37-43. 
  2. Suzuki J, Takaku A, Kodama N, Sato S. An attempt to treat cerebrovascular «Moyamoya» disease in children. Child’s Brain. 1975;1(4):193-206.  https://doi.org/10.1159/000119568
  3. Weidner W, Hanafeewmarkham CH. Intracranial collateral circulation via leptomeningeal and rete mirabile anastomoses. Neurology. 1965;15:39-48.  https://doi.org/10.1212/wnl.15.1.39
  4. Leeds NE, Abbott KH. Collateral circulation in cerebrovascular disease in childhood via rete mirabile and perforating branches of anterior choroidal and posterior cerebral arteries. Radiology. 1965;85(4):628-634.  https://doi.org/10.1148/85.4.628
  5. Suzuki J, Takaku A. Cerebrovascular «moyamoya» disease. Disease showing abnormal net-like vessels in base of brain. Archives of Neurology. 1969;20(3):288-299.  https://doi.org/10.1001/archneur.1969.00480090076012
  6. Kudo T. Spontaneous occlusion of the circle of Willis. A disease apparently confined to Japanese. Neurology. 1968;18(5):485-496.  https://doi.org/10.1212/wnl.18.5.485
  7. Nishimoto A, Takeuchi S. Abnormal cerebrovascular network related to the internal cartoid arteries. Journal of Neurosurgery. 1968;29(3):255-260.  https://doi.org/10.3171/jns.1968.29.3.0255
  8. Baba T, Houkin K, Kuroda S. Novel epidemiological features of moyamoya disease. Journal of Neurology, Neurosurgery and Psychiatry. 2008;79(8):900-904.  https://doi.org/10.1136/jnnp.2007.130666
  9. Kuriyama S, Kusaka Y, Fujimura M, Wakai K, Tamakoshi A, Hashimoto S, Tsuji I, Inaba Y, Yoshimoto T. Prevalence and Clinicoepidemiological Features of Moyamoya Disease in Japan. Stroke. 2008;39(1):42-47.  https://doi.org/10.1161/STROKEAHA.107.490714
  10. Miao W, Zhao P, Zhang Y, Liu H, Chang Y, Ma J, Huang QJ, Lou ZX. Epidemiological and clinical features of Moyamoya disease in Nanjing, China. Clinical Neurology and Neurosurgery. 2010;112(3):199-203.  https://doi.org/10.1016/j.clineuro.2009.11.009
  11. Uchino K, Johnston SC, Becker KJ, Tirschwell DL. Moyamoya disease in Washington State and California. Neurology. 2005;65(6):956-958.  https://doi.org/10.1212/01.wnl.0000176066.33797.82
  12. Yonekawa Y, Ogata N, Kaku Y, Taub E, Imhof HG. Moyamoya disease in Europe, past and present status. Clinical Neurology and Neurosurgery. 1997;99(suppl 2):58-60.  https://doi.org/10.1016/s0303-8467(97)00042-5
  13. Korshunov AE, Pronin IN, Golovteev AL. Moyamoya disease is a treatable cause of repeated ischemic strokes in children. Russkij zhurnal detskoj nevrologii. 2010;5(1):27-34. (In Russ.).
  14. Samitova ER, Mazankova LN, Mosin IM, Osmanov IM, Zykov VP, Akhadov TA, Melnikov IA, Koroid NV, Tambiev IE, Dikova EA, Elfimova OI, Getmanchenko YuG. Moyamoya disease in the practice of a pediatric infectious disease specialist. Rossijskij vestnik perinatologii i pediatrii. 2017;62(2):78-83. (In Russ.).
  15. Kovalenko AP, Shopin VN, Penner VA, Scherbin AV. Moyamoya disease: a case from practice. Endovaskulyarna nejrorentgenohіrurgіya. 2013;3(5):054-061. (In Russ.).
  16. Lvov OA, Gusev VV, Kovtun OP. Is Moyamoya disease the only and sufficient reason for acute cerebrovascular accident? Trudnyj pacient. 2017;10-11:45-48. (In Russ.).
  17. Petrukhin AS, Mukhin KYu, Alikhanov AA, Kulikov SV, Abbasova AA. Moyamoya syndrome in a patient with type I neurofibromatosis. Nevrologicheskij zhurnal. 1999;6:16-18. (In Russ.).
  18. Panuntsev VS, Khristoforova MI. Moyamoya disease and syndrome. Nejrohirurgiya. 2001;3:6-11. (In Russ.).
  19. Khachatryan VA, Samochernykh KA, Trofimova TN. Bolezn’ i sindrom Mojya-Mojya u detej. Cerebrovaskulyarnaya patologiya u detej. SPb: Desyatka; 2006. (In Russ.).
  20. Litvinenko PV. Nepryamye revaskulyariziruyushchie operacii u detej so strukturnymi porazheniyami golovnogo mozga: Dis. ... kand. med. nauk. SPb. 2018. (In Russ.).
  21. Smith ER, Scott RM. Moyamoya: epidemiology, presentation, and diagnosis. Neurosurgery Clinics of North America. 2010;21(3):543-551.  https://doi.org/10.1016/j.nec.2010.03.007
  22. Mineharu Y. Inheritance pattern of familial moyamoya disease: autosomal dominant mode and genomic imprinting. Journal of Neurology, Neurosurgery and Psychiatry. 2006;77(9):1025-1029.
  23. Mineharu Y, Liu W, Inoue K, Matsuura N, Inoue S, Takenaka K, Ikeda H, Houkin K, Takagi Y, Kikuta K, Nozaki K, Hashimoto N, Koizumi A. Autosomal dominant moyamoya disease maps to chromosome 17q25.3. Neurology. 2008;70(Issue 24, Part 2):357-363.  https://doi.org/10.1212/01.wnl.0000291012.49986.f9
  24. Kamada F, Aoki Y, Narisawa A, Abe Y, Komatsuzaki S, Kikuchi A, Kanno J, Niihori T, Ono M, Ishii N, Owada Y, Fujimura M, Mashimo Y, Suzuki Y, Hata A, Tsuchiya S, Tominaga T, Matsubara Y, Kure S. A genome-wide association study identifies RNF213 as the first Moyamoya disease gene. Journal of Human Genetics. 2011;56(1):34-40.  https://doi.org/10.1038/jhg.2010.132
  25. Fujimura M, Sonobe S, Nishijima Y, Niizuma K, Sakata H, Kure S, Tominaga T.Genetics and Biomarkers of Moyamoya Disease: Significance of RNF213 as a Susceptibility Gene. Journal of Stroke. 2014;16(2):65-72.  https://doi.org/0.5853/jos.2014.16.2.65
  26. Kanoke A, Fujimura M, Niizuma K, Ito A, Sakata H, Sato-Maeda M, Morita-Fujimura Y, Kure S, Tominaga T.Temporal profile of the vascular anatomy evaluated by 9.4-tesla magnetic resonance angiography and histological analysis in mice with the R4859K mutation of RNF213, the susceptibility gene for moyamoya disease. Brain Research. 2015;1624:497-505.  https://doi.org/10.1016/j.brainres.2015.07.039
  27. Takagi Y, Kikuta K, Nozaki K, Hashimoto N. Histological features of middle cerebral arteries from patients treated for Moyamoya disease. Neurologia Medico-Chirurgica. 2007;47(1):1-4.  https://doi.org/10.2176/nmc.47.1
  28. Lin R, Xie Z, Zhang J, Xu H, Su H, Tan X, Tian D, Su M. Clinical and immunopathological features of Moyamoya disease. PLoS One. 2012;7(4):e36386. https://doi.org/10.1371/journal.pone.0036386
  29. Wakai K, Tamakoshi A, Ikezaki K, Fukui M, Kawamura T, Aoki R, Kojima M, Lin Y, Ohno Y. Epidemiological features of moyamoya disease in Japan: findings from a nationwide survey. Clinical Neurology and Neurosurgery. 1997;99(suppl 2):1-5.  https://doi.org/10.1016/s0303-8467(97)00031-0
  30. Kuroda S, Houkin K. Moyamoya disease: current concepts and future perspectives. The Lancet Neurology. 2008;7(11):1056-1066. https://doi.org/10.1016/S1474-4422(08)70240-0
  31. Fukui M, Kono S, Sueishi K, Ikezaki K. Moyamoya disease. Neuropathology. 2000;20(suppl):61-64.  https://doi.org/10.1046/j.1440-1789.2000.00300.x
  32. Kim JS. Moyamoya Disease: Epidemiology, Clinical Features, and Diagnosis. Journal of Stroke. 2016;18(1):2-11.  https://doi.org/10.5853/jos.2015.01627
  33. Kawaguchi S, Sakaki T, Morimoto T, Kakizaki T, Kamada K. Characteristics of intracranial aneurysms associated with moyamoya disease. A review of 111 cases. Acta Neurochirurgica. 1996;138(11):1287-1294. https://doi.org/10.1007/bf01411057
  34. Liu ZW, Han C, Zhao F, Qiao PG, Wang H, Bao XY, Zhang ZS, Yang WZ, Li DS, Duan L. Collateral Circulation in Moyamoya Disease: A New Grading System. Stroke. 2019;50(10):2708-2715. https://doi.org/10.1161/STROKEAHA.119.024487
  35. Funaki T, Takahashi JC, Houkin K, Kuroda S, Takeuchi S, Fujimura M, Tomata Y, Miyamoto S. Angiographic features of hemorrhagic moyamoya disease with high recurrence risk: a supplementary analysis of the Japan Adult Moyamoya Trial. Journal of Neurosurgery. 2018;128(3):777-784.  https://doi.org/10.3171/2016.11.JNS161650
  36. Yamada M, Fujii K, Fukui M. Clinical features and outcomes in patients with asymptomatic moyamoya disease — from the results of nation-wide questionnaire survey. No To Shinkei: Brain and Nerve. 2005;33(4):337-342. 
  37. Kuroda S. AMORE Study Group. Asymptomatic moyamoya disease: literature review and ongoing AMORE study. Neurologia Medico-Chirurgica. 2015;55(3):194-198.  https://doi.org/10.2176/nmc.ra.2014-0305
  38. Kuroda S, Hashimoto N, Yoshimoto T, Iwasaki Y; Research Committee on Moyamoya Disease in Japan. Radiological Findings, Clinical Course, and Outcome in Asymptomatic Moyamoya Disease. Stroke. 2007;38(5):1430-1435. https://doi.org/10.1161/STROKEAHA.106.478297
  39. Hallemeier CL, Rich KM, Grubb RL Jr, Chicoine MR, Moran CJ, Cross DT 3rd, Zipfel GJ, Dacey RG Jr, Derdeyn CP. Clinical features and outcome in North American adults with moyamoya phenomenon. Stroke. 2006;37(6):1490-1496. https://doi.org/10.1161/01.STR.0000221787.70503.ca
  40. Fullerton HJ, Wintermark M, Hills NK, Dowling MM, Tan M, Rafay MF, Elkind MS, Barkovich AJ, deVeber GA; VIPS Investigators. Risk of Recurrent Arterial Ischemic Stroke in Childhood: A Prospective International Study. Stroke. 2016;47(1):53-59.  https://doi.org/10.1161/STROKEAHA.115.011173
  41. Kurokawa T, Tomita S, Ueda K, Narazaki O, Hanai T, Hasuo K, Matsushima T, Kitamura K. Prognosis of occlusive disease of the circle of Willis (moyamoya disease) in children. Pediatric Neurology. 1985;1(5):274-277.  https://doi.org/10.1016/0887-8994(85)90027-x
  42. Yoshida Y, Yoshimoto T, Shirane R, Sakurai Y. Clinical course, surgical management, and long-term outcome of moyamoya patients with rebleeding after an episode of intracerebral hemorrhage: An extensive follow-Up study. Strok. 1999;30(11):2272-2276. https://doi.org/10.1161/01.str.30.11.2272
  43. Morioka M, Hamada J, Todaka T, Yano S, Kai Y, Ushio Y. High-risk age for rebleeding in patients with hemorrhagic moyamoya disease: long-term follow-up study. Neurosurgery. 2003;52(5):1049-1054.
  44. Fukui M. Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis («moyamoya» disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan. Clinical Neurology and Neurosurgery. 1997;99(suppl 2):238-240. 
  45. Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis; Health Labour Sciences Research Grant for Research on Measures for Infractable Diseases. Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis). Neurologia Medico-Chirurgica. 2012;52(5):245-266.  https://doi.org/10.2176/nmc.52.245
  46. Scott RM, Smith ER. Moyamoya disease and moyamoya syndrome. New England Journal of Medicine. 2009;360(12):1226-1237. https://doi.org/10.1056/NEJMra0804622
  47. Hasuo K, Mihara F, Matsushima T. MRI and MR angiography in moyamoya disease. Journal of Magnetic Resonance Imaging. 1998;8(4):762-766.  https://doi.org/10.1002/jmri.1880080403
  48. Seo KD, Suh SH, Kim YB, Kim JH, Ahn SJ, Kim DS, Lee KY. Ivy Sign on Fluid-Attenuated Inversion Recovery Images in Moyamoya Disease: Correlation with Clinical Severity and Old Brain Lesions. Yonsei Medical Journal. 2015;56(5):1322-1327. https://doi.org/10.3349/ymj.2015.56.5.1322
  49. Mori N, Mugikura S, Higano S, Kaneta T, Fujimura M, Umetsu A, Murata T, Takahashi S.The leptomeningeal «ivy sign» on fluid-attenuated inversion recovery MR imaging in Moyamoya disease: a sign of decreased cerebral vascular reserve? AJNR: American Journal of Neuroradiology. 2009;30(5):930-935.  https://doi.org/10.3174/ajnr.A1504
  50. Nam KW, Cho WS, Kwon HM, Kim JE, Lee YS, Park SW, Rhim JH, Son YJ. Ivy Sign Predicts Ischemic Stroke Recurrence in Adult Moyamoya Patients without Revascularization Surgery. Cerebrovascular Diseases. 2019;47(5-6):223-230.  https://doi.org/10.1159/000500610
  51. Song P, Qin J, Yu Y, Shi C, Qiao P, Xie A, Li G. Comparative Performance of Magnetic Resonance Angiography and Digital Subtraction Angiography in Vessel Involvement of Pediatric Moyamoya Disease. Iranian Journal of Radiology. 2019;16(1):e55595. https://doi.org/10.5812/iranjradiol.55595
  52. Yamada I, Nakagawa T, Matsushima Y, Shibuya H. High-resolution turbo magnetic resonance angiography for diagnosis of Moyamoya disease. Stroke. 2001;32(8):1825-1831. https://doi.org/10.1161/01.str.32.8.1825
  53. Houkin K, Nakayama N, Kuroda S, Nonaka T, Shonai T, Yoshimoto T. Novel Magnetic Resonance Angiography Stage Grading for Moyamoya Disease. Cerebrovascular Diseases. 2005;20(5):347-354.  https://doi.org/10.1159/000087935
  54. Hendrikse J, Klijn CJ, van Huffelen AC, Kappelle LJ, van der Grond J. Diagnosing cerebral collateral flow patterns: accuracy of non-invasive testing. Cerebrovascular Diseases. 2008;25(5):430-437.  https://doi.org/10.1159/000121344
  55. Mugikura S, Takahashi S, Higano S, Shirane R, Kurihara N, Furuta S, Ezura M, Takahashi A. The relationship between cerebral infarction and angiographic characteristics in childhood moyamoya disease. AJNR: American Journal of Neuroradiology. 1999;20(2):336-343. 
  56. Storey A, Michael Scott R, Robertson R, Smith E. Preoperative transdural collateral vessels in moyamoya as radiographic biomarkers of disease. Journal of Neurosurgery. Pediatrics. 2017;19(3):289-295.  https://doi.org/10.3171/2016.9.PEDS16161
  57. Lee M, Zaharchuk G, Guzman R, Achrol A, Bell-Stephens T, Steinberg GK. Quantitative hemodynamic studies in moyamoya disease: a review. Neurosurgical Focus. 2009;26(4):E5.  https://doi.org/10.3171/2009.1.FOCUS08300
  58. Rim NJ, Kim HS, Shin YS, Kim SY. Which CT perfusion parameter best reflects cerebrovascular reserve?: Correlation of acetazolamide-challenged CT perfusion with single-photon emission CT in Moyamoya patients. AJNR: American Journal of Neuroradiology. 2008;29(9):1658-1663. https://doi.org/10.3174/ajnr.A1229
  59. Hokari M, Kuroda S, Shiga T, Nakayama N, Tamaki N, Iwasaki Y. Combination of a mean transit time measurement with an acetazolamide test increases predictive power to identify elevated oxygen extraction fraction in occlusive carotid artery diseases Journal of Nuclear Medicine. 2008;49(12):1922-1927. https://doi.org/10.2967/jnumed.108.054379
  60. Latchaw RE, Yonas H, Pentheny SL, Gur D. Adverse reactions to xenon-enhanced CT cerebral blood flow determination. Radiology. 1987;163(1):251-254.  https://doi.org/10.1148/radiology.163.1.3823444
  61. Pronin IN, Fadeeva LM, Podoprigora AE, Zakharova NE, Serkov CB, Rodionov PV, Shults EI, Korshunov AE, Usachev DYu, Lukshin VA, Celik A, Potapov AA, Kornienko VI. Spin Labeling of Arterial Blood (ASL) — A method for visualizing and evaluating cerebral blood flow. Luchevaya diagnostika i terapiya. 2012;3(3):64-78. (In Russ.).
  62. Goetti R, O’Gorman R, Khan N, Kellenberger CJ, Scheer I. Arterial spin labelling MRI for assessment of cerebral perfusion in children with moyamoya disease: comparison with dynamic susceptibility contrast MRI. Neuroradiology. 2013;55(5):639-647.  https://doi.org/10.1007/s00234-013-1155-8
  63. Amukotuwa SA, Yu C, Zaharchuk G. 3D Pseudocontinuous arterial spin labeling in routine clinical practice: A review of clinically significant artifacts. Journal of Magnetic Resonance Imaging. 2016;43(1):11-27.  https://doi.org/10.1002/jmri.24873
  64. Hara S, Tanaka Y, Ueda Y, Abe D, Hayashi S, Inaji M, Maehara T, Ishii K, Nariai T. Detection of hemodynamic impairment on (15)O gas PET using visual assessment of arterial spin-labeling MR imaging in patients with moyamoya disease. Journal of Clinical Neuroscience. 2020;72:258-263.  https://doi.org/10.1016/j.jocn.2019.11.026
  65. Bokkers RP, De Cocker LJ, van Osch MJ, Hartkamp NS, Hendrikse J. Selective Arterial Spin Labeling: Techniques and Neurovascular Applications. Top Magnetic Resonance Imaging. 2016;25(2):73-80.  https://doi.org/10.1097/RMR.0000000000000078
  66. Kurlemann G, Fahrendorf G, Krings W, Sciuk J, Palm D. Characteristic EEG findings in childhood moyamoya syndrome. Neurosurgical Review. 1992;15(1):57-60.  https://doi.org/10.1007/bf02352069
  67. Czabanka M, Peña-Tapia P, Schubert GA, Heppner FL, Martus P, Horn P, Schmiedek P, Vajkoczy P. Proposal for a New Grading of Moyamoya Disease in Adult Patients. Cerebrovascular Diseases. 2011;32(1):41-50.  https://doi.org/10.1159/000326077
  68. Fung LW, Thompson D, Ganesan V. Revascularisation surgery for paediatric moyamoya: a review of the literature. Child’s Nervous System. 2005;21(5):358-364.  https://doi.org/10.1007/s00381-004-1118-9
  69. Sun H, Wilson C, Ozpinar A, Safavi-Abbasi S, Zhao Y, Nakaji P, Wanebo JE, Spetzler RF. Perioperative Complications and Long-Term Outcomes after Bypasses in Adults with Moyamoya Disease: A Systematic Review and Meta-Analysis. World Neurosurgery. 2016;92:179-188.  https://doi.org/10.1016/j.wneu.2016.04.083
  70. Houkin K, Kamiyama H, Abe H, Takahashi A, Kuroda S. Surgical therapy for adult moyamoya disease. Can surgical revascularization prevent the recurrence of intracerebral hemorrhage? Stroke. 1996;27(8):1342-1346. https://doi.org/10.1161/01.str.27.8.1342
  71. Miyamoto S, Yoshimoto T, Hashimoto N, Okada Y, Tsuji I, Tominaga T, Nakagawara J, Takahashi JC; JAM Trial Investigators. Effects of extracranial-intracranial bypass for patients with hemorrhagic moyamoya disease: results of the Japan Adult Moyamoya Trial. Stroke. 2014;45(5):1415-1421. https://doi.org/10.1161/STROKEAHA.113.004386
  72. Zipfel GJ, Fox DJ Jr, Rivet DJ. Moyamoya disease in adults: the role of cerebral revascularization. Skull Base. 2005;15(1):27-41.  https://doi.org/10.1055/s-2005-868161
  73. Fujii K, Ikezaki K, Irikura K, Miyasaka Y, Fukui M. The efficacy of bypass surgery for the patients with hemorrhagic moyamoya disease. Clinical Neurology and Neurosurgery. 1997;99(2):00078-4.  https://doi.org/10.1016/s0303-8467(97)00078-4
  74. Iwama T, Hashimoto N, Murai BN, Tsukahara T, Yonekawa Y. Intracranial rebleeding in moyamoya disease. Journal of Clinical Neuroscience. 1997;4(2):169-172.  https://doi.org/10.1016/s0967-5868(97)90068-0
  75. Ferriero DM, Fullerton HJ, Bernard TJ, Billinghurst L, Daniels SR, DeBaun MR, deVeber G, Ichord RN, Jordan LC, Massicotte P, Meldau J, Roach ES, Smith ER; American Heart Association Stroke Council and Council on Cardiovascular and Stroke Nursing. Management of Stroke in Neonates and Children: A Scientific Statement From the American Heart Association/American Stroke Association. Stroke. 2019;50(3):51-96.  https://doi.org/10.1161/STR.0000000000000183
  76. Luo R, Gao F, Deng X, Zhang D, Zhang Y. Results of Conservative Follow-up or Surgical Treatment of Moyamoya Patients Who Present without Hemorrhage, Transient Ischemic Attack, or Stroke. World Neurosurgery. 2017;108:683-689.  https://doi.org/10.1016/j.wneu.2017.09.056
  77. Krayenbühl HA. The Moyamoya syndrome and the neurosurgeon. Surgical Neurology. 1975;4(4):353-360. 
  78. Duckworth EA, Rao VY, Patel AJ. Double-barrel bypass for cerebral ischemia: technique, rationale, and preliminary experience with 10 consecutive cases. Neurosurgery. 2013;73(1 Suppl Operative):30-38; discussion ons37-38.  https://doi.org/10.1227/NEU.0b013e318285b587
  79. Ravina K, Yim B, Lam J, Strickland BA, Carey JN, Russin JJ. Three-Vessel Anastomosis for Direct Bihemispheric Cerebral Revascularization. Operative Neurosurgery (Hagerstown). 2019:opz401. https://doi.org/10.1093/ons/opz401
  80. Arnone GD, Hage ZA, Charbel FT. Single Vessel Double Anastomosis for Flow Augmentation — A Novel Technique for Direct Extracranial to Intracranial Bypass Surgery. Operative Neurosurgery (Hagerstown). 2019;17(4):365-375.  https://doi.org/0.1093/ons/opy396
  81. Sakamoto H, Kitano S, Yasui T, Komiyama M, Nishikawa M, Iwai Y, Yamanaka K, Nakajima H, Kishi H, Kan M, Fujitani K, Hakuba A. Direct extracranial-intracranial bypass for children with moyamoya disease. Clinical Neurology and Neurosurgery. 1997;99(2):128-133. 
  82. Jeon JP, Kim JE, Cho WS, Bang JS, Son YJ, Oh CW. Meta-analysis of the surgical outcomes of symptomatic moyamoya disease in adults. Journal of Neurosurgery. 2018;128(3):793-799.  https://doi.org/10.3171/2016.11.JNS161688
  83. Kim T, Oh CW, Kwon OK, Hwang G, Kim JE, Kang HS, Cho WS, Bang JS. Stroke prevention by direct revascularization for patients with adult-onset moyamoya disease presenting with ischemia. Journal of Neurosurgery. 2016;124(6):1788-1793. https://doi.org/10.3171/2015.6.JNS151105
  84. Lee SB, Kim DS, Huh PW, Yoo DS, Lee TG, Cho KS. Long-term follow-up results in 142 adult patients with moyamoya disease according to management modality. Acta Neurochirurgica. 2012;154(7):1179-1187. https://doi.org/10.1007/s00701-012-1325-1
  85. Tu XK, Fujimura M, Rashad S, Mugikura S, Sakata H, Niizuma K, Tominaga T. Uneven cerebral hemodynamic change as a cause of neurological deterioration in the acute stage after direct revascularization for moyamoya disease: cerebral hyperperfusion and remote ischemia caused by the «watershed shift». Neurosurgical Review. 2017;40(3):507-512.  https://doi.org/10.1007/s10143-017-0845-9
  86. Tashiro R, Fujimura M, Kameyama M, Mugikura S, Endo H, Takeuchi Y, Tomata Y, Niizuma K, Tominaga T. Incidence and Risk Factors of the Watershed Shift Phenomenon after Superficial Temporal Artery-Middle Cerebral Artery Anastomosis for Adult Moyamoya Disease. Cerebrovascular Diseases. 2019;47(3-4):178-187.  https://doi.org/10.1159/000500802
  87. Lukshin VA, Usachev DYu, Shulgina AA, Shevchenko EV. Local cerebral hemodynamics following STA-MCA bypass in patients with symptomatic carotid occlusions. Voprosy neirokhirurgii imeni N.N. Burdenko.2019;83(3):29-41. (In Russ.). https://doi.org/10.17116/neiro20198303129
  88. Houkin K, Kuroda S, Ishikawa T, Abe H. Neovascularization (angiogenesis) after revascularization in moyamoya disease. Which technique is most useful for moyamoya disease? Acta Neurochirurgica. 2000;142(3):269-276.  https://doi.org/10.1007/s007010050035
  89. Hirano T, Mikami T, Suzuki H, Hirano T, Kimura Y, Komatsu K, Akiyama Y, Wanibuchi M, Mikuni N. Occipital Artery to Middle Cerebral Artery Bypass in Cases of Unavailable Superficial Temporal Artery. World Neurosurgery. 2018;112:101-108.  https://doi.org/10.1016/j.wneu.2018.01.103
  90. Teo M, Johnson J, Steinberg GK. Strategies for and Outcome of Repeat Revascularization Surgery for Moyamoya Disease: An American Institutional Series. Neurosurgery. 2017;81(5):852-859.  https://doi.org/10.1093/neuros/nyx122
  91. Iwama T, Hashimoto N, Tsukahara T, Miyake H. Superficial temporal artery to anterior cerebral artery direct anastomosis in patients with moyamoya disease. Clinical Neurology and Neurosurgery. 1997;99(2):74-77.  https://doi.org/10.1016/s0303-8467(97)00074-7
  92. Kawashima A, Kawamata T, Yamaguchi K, Hori T, Okada Y. Successful superficial temporal artery-anterior cerebral artery direct bypass using a long graft for moyamoya disease: technical note. Neurosurgery. 2010;67(3 suppl Operative):40.  https://doi.org/10.1227/01.NEU.0000382975.86267.40
  93. Kinugasa K, Mandai S, Tokunaga K, Kamata I, Sugiu K, Handa A, Ohmoto T. Ribbon enchephalo-duro-arterio-myo-synangiosis for moyamoya disease. Surgical Neurology. 1994;41(6):455-461.  https://doi.org/10.1016/0090-3019(94)90007-8
  94. Reis CV, Safavi-Abbasi S, Zabramski JM, Gusmão SN, Spetzler RF, Preul MC. The history of neurosurgical procedures for moyamoya disease. Neurosurgical Focus. 2006;20(6):7.  https://doi.org/10.3171/foc.2006.20.6.7
  95. Karasawa J, Kikuchi H, Furuse S, Kawamura J, Sakaki T. Treatment of moyamoya disease with STA-MCA anastomosis. Journal of Neurosurgery. 1978;49(5):679-688.  https://doi.org/10.3171/jns.1978.49.5.0679
  96. Matsushima Y, Fukai N, Tanaka K, Tsuruoka S, Inaba Y, Aoyagi M, Ohno K. A new surgical treatment of moyamoya disease in children: a preliminary report. Surgical Neurology. 1981;15(4):313-320.  https://doi.org/10.1016/s0090-3019(81)80017-1
  97. Karasawa J, Kikuchi H, Kawamura J, Sakai T. Intracranial transplantation of the omentum for cerebrovascular moyamoya disease: a two-year follow-up study. Surgical Neurology. 1980;14(6):444-449. 
  98. Kuroda S, Houkin K, Ishikawa T, Nakayama N, Iwasaki Y. Novel bypass surgery for moyamoya disease using pericranial flap: its impacts on cerebral hemodynamics and long-term outcome. Neurosurgery. 2010;66(6):1093-1101. https://doi.org/10.1227/01.NEU.0000369606.00861.91
  99. Shen W, Xu B, Li H, Gao X, Liao Y, Shi W, Zhao R, Zhang Y. Enlarged Encephalo-Duro-Myo-Synangiosis Treatment for Moyamoya Disease in Young Children. World Neurosurgery. 2017;106:9-16.  https://doi.org/10.1016/j.wneu.2017.06.088
  100. Irikura K, Miyasaka Y, Kurata A, Tanaka R, Yamada M, Kan S, Fujii K. The effect of encephalo-myo-synangiosis on abnormal collateral vessels in childhood moyamoya disease. Neurological Research. 2000;22(4):341-346.  https://doi.org/10.1080/01616412.2000.11740680
  101. Kim SK, Wang KC, Kim IO, Lee DS, Cho BK. Combined encephaloduroarteriosynangiosis and bifrontal encephalogaleo(periosteal)synangiosis in pediatric moyamoya disease. Neurosurgery. 2002;50(1):88-96.  https://doi.org/10.1097/00006123-200201000-00016
  102. Kawaguchi T, Fujita S, Hosoda K, Shose Y, Hamano S, Iwakura M, Tamaki N. Multiple burr-hole operation for adult moyamoya disease. Journal of Neurosurgery. 1996;84(3):468-476.  https://doi.org/10.3171/jns.1996.84.3.0468
  103. Czabanka M, Peña-Tapia P, Scharf J, Schubert GA, Münch E, Horn P, Schmiedek P, Vajkoczy P. Characterization of direct and indirect cerebral revascularization for the treatment of European patients with moyamoya disease. Cerebrovascular Diseases. 2011;32(4):361-369.  https://doi.org/10.1159/000330351
  104. Scott RM, Smith JL, Robertson RL, Madsen JR, Soriano SG, Rockoff MA. Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis. Journal of Neurosurgery. 2004;100(2 suppl Pediatrics):142-149.  https://doi.org/10.3171/ped.2004.100.2.0142
  105. Guzman R, Lee M, Achrol A, Bell-Stephens T, Kelly M, Do HM, Marks MP, Steinberg GK. Clinical outcome after 450 revascularization procedures for moyamoya disease. Journal of Neurosurgery. 2009;111(5):927-935.  https://doi.org/10.3171/2009.4.JNS081649
  106. Houkin K, Kamiyama H, Takahashi A, Kuroda S, Abe H. Combined revascularization surgery for childhood moyamoya disease: STA-MCA and encephalo-duro-arterio-myo-synangiosis. Child’s Nervous System. 1997;13(1):24-29.  https://doi.org/10.1007/s003810050034
  107. Kazumata K, Ito M, Tokairin K, Ito Y, Houkin K, Nakayama N, Kuroda S, Ishikawa T, Kamiyama H. The frequency of postoperative stroke in moyamoya disease following combined revascularization: a single-university series and systematic review. Journal of Neurosurgery. 2014;121(2):432-440.  https://doi.org/10.3171/2014.1.JNS13946
  108. Ishikawa T, Houkin K, Kamiyama H, Abe H. Effects of surgical revascularization on outcome of patients with pediatric moyamoya disease. Stroke. 1997;28(6):1170-1173. https://doi.org/10.1161/01.str.28.6.1170
  109. Cho WS, Kim JE, Kim CH, Ban SP, Kang HS, Son YJ, Bang JS, Sohn CH, Paeng JC, Oh CW. Long-term outcomes after combined revascularization surgery in adult moyamoya disease. Stroke. 2014;45(10):3025-3031. https://doi.org/10.1161/STROKEAHA.114.005624
  110. Matsushima T, Inoue T, Ikezaki K, Matsukado K, Natori Y, Inamura T, Fukui M. Multiple combined indirect procedure for the surgical treatment of children with moyamoya disease. A comparison with single indirect anastomosis and direct anastomosis. Neurosurgical Focus. 1998;5(5):7.  https://doi.org/10.3171/foc.1998.5.5.7
  111. Zhao M, Deng X, Zhang D, Wang S, Zhang Y, Wang R, Zhao J. Risk factors for and outcomes of postoperative complications in adult patients with moyamoya disease. Journal of Neurosurgery. 2018;1-12. Online ahead of print. https://doi.org/10.3171/2017.10.JNS171749
  112. Jang DK, Lee KS, Rha HK, Huh PW, Yang JH, Park IS, Ahn JG, Sung JH, Han YM. Bypass surgery versus medical treatment for symptomatic moyamoya disease in adults. Journal of Neurosurgery. 2017;127(3):492-502.  https://doi.org/10.3171/2016.8.JNS152875
  113. Liu JJ, Steinberg GK. Direct Versus Indirect Bypass for Moyamoya Disease. Neurosurgery Clinics of North America. 2017;28(3):361-374.  https://doi.org/10.1016/j.nec.2017.02.004
  114. Kuroda S, Nakayama N, Yamamoto S, Kashiwazaki D, Uchino H, Saito H, Hori E, Akioka N, Kuwayama N, Houkin K. Late (5—20 years) outcomes after STA-MCA anastomosis and encephalo-duro-myo-arterio-pericranial synangiosis in patients with moyamoya disease. Journal of Neurosurgery. 2020;13:1-8.  https://doi.org/10.3171/2019.12.JNS192938
  115. Acker G, Goerdes S, Schneider UC, Schmiedek P, Czabanka M, Vajkoczy P. Distinct clinical and radiographic characteristics of moyamoya disease amongst European Caucasians. European Journal of Neurology. 2015;22(6):1012-1017. https://doi.org/10.1111/ene.12702
  116. Feghali J, Xu R, Yang W, Liew JA, Blakeley J, Ahn ES, Tamargo RJ, Huang J. Moyamoya disease versus moyamoya syndrome: comparison of presentation and outcome in 338 hemispheres. Journal of Neurosurgery. 2019;1-9. Online ahead of print. https://doi.org/10.3171/2019.6.JNS191099
  117. Khan N, Yonekawa Y. Multiple Extracranial-Intracranial Bypass Surgery in Moyamoya Angiopathy. Moyamoya Disease: Diagnosis and Treatment. Thieme Medical Publishers, Inc.; 2014.
  118. Sato Y, Kazumata K, Nakatani E, Houkin K, Kanatani. Characteristics of Moyamoya Disease Based on National Registry Data in Japan. Stroke. 2019;50(8):1973-1980. https://doi.org/10.1161/STROKEAHA.119.024689
  119. Gaillard J, Klein J, Duran D, Storey A, Scott RM, Kahle K, Smith ER. Incidence, clinical features, and treatment of familial moyamoya in pediatric patients: a single-institution series. Journal of Neurosurgery. Pediatrics. 2017;19(5):553-559.  https://doi.org/10.3171/2016.12.PEDS16468
  120. Zhao J, Liu H, Zou Y, Zhang W, He S. Clinical and angiographic outcomes after combined direct and indirect bypass in adult patients with moyamoya disease: A retrospective study of 76 procedures. Experimental and Therapeutic Medicine. 2018;15(4):3570-3576. https://doi.org/10.3892/etm.2018.5850
  121. Amin-Hanjani S, Singh A, Rifai H, Thulborn KR, Alaraj A, Aletich V, Charbel FT. Combined direct and indirect bypass for moyamoya: quantitative assessment of direct bypass flow over time. Neurosurgery. 2013;73(6):962-967.  https://doi.org/10.1227/NEU.0000000000000139
  122. Jung YJ, Ahn JS, Kwon DH, Kwun BD. Ischemic complications occurring in the contralateral hemisphere after surgical treatment of adults with moyamoya disease. Journal of Korean Neurosurgical Society. 2011;50(6):492-496.  https://doi.org/10.3340/jkns.2011.50.6.492
  123. Kansha M, Irita K, Takahashi S, Matsushima T. Anesthetic management of children with moyamoya disease. Clinical Neurology and Neurosurgery. 1997;99(2):00068-1.  https://doi.org/10.1016/s0303-8467(97)00068-1
  124. Iwama T, Hashimoto N, Yonekawa Y. The relevance of hemodynamic factors to perioperative ischemic complications in childhood moyamoya disease. Neurosurgery. 1996;38(6):1120-1125; discussion 1125-1126. https://doi.org/10.1097/00006123-199606000-00011

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.